Low-dose Aspirin Use between the Case (1–56 days) and Control Periods (57–112 days) for Major Hemorrhagic Risks by Patient Characteristics.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Low-dose Aspirin Use between the Case (1–56 days) and Control Periods (57–112 days) for Major Hemorrhagic Risks by Patient Characteristics.
创建时间：
2014-05-30
